Subjecting horse spermatozoa to hypoosmotic incubation: Effects of ouabain
Theriogenology, ISSN: 0093-691X, Vol: 47, Issue: 3, Page: 765-784
1997
- 29Citations
- 14Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations29
- Citation Indexes29
- 29
- CrossRef22
- Captures14
- Readers14
- 14
Article Description
Although hypoosmotic tests are widely used to assess spermatozoal quality in different species, they have not been used extensively in the stallion. Moreover, the role of the Na+K+, ouabain sensitive-ATP-ase in the response of equine sperm to hypoosmotic shock is not well understood. This study tests two hypotheses: 1) that equine spermatozoa will respond to a hypoosmotic medium by swelling of the tail, and 2) that addition of ouabain will increase the percentage of swollen sperm tails. Ejaculates from 3 stallions were collected with an artificial vagina and diluted in Kenney's medium (Time = 0). Aliquots were randomly selected to be incubated in an isoosmotic (297 mOsm) or different hypoosmotic media that were composed of citrate or of citrate wïth fructose. The osmolarity of the hypoosmotic media with citrate ranged from 18 to 96 mOsm, and the medium composed of citrate plus fructose (HOS medium) was of 153 mOsm. Moreover, aliquots of spermatozoa pretreated with ouabain were added to the isoosmotic medium and also to the HOS and the 96 mOsm citrate medium (ORT medium). Incubation of equine sperm in the hypoosmotic media resulted in a time- and osmolarity-dependent swelling of the sperm tail, reaching maximum values after incubation for 20–30 min in both the HOS and ORT media. Ouabain induced a dose-dependent effect on swollen tails and viability in fresh semen and also affected some parameters related to motility. Ouabain also increased the swelling response in a hypoosmotic medium although viability decreased. The percentage of swollen tails after incubation in ORT and HOS media snowed significant correlations to viability, altered acrosomes and total motility, but not to other parameters of horse semen analysis. Our results suggest that hypoosmotic tests could be used to improve standard horse semen analysis. Additionally, Na+K+ -ATP-ase activity could be related to the response against hypoosmotic shock of horse spermatozoa.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0093691X97000332; http://dx.doi.org/10.1016/s0093-691x(97)00033-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0031062351&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/16728027; https://linkinghub.elsevier.com/retrieve/pii/S0093691X97000332; http://linkinghub.elsevier.com/retrieve/pii/S0093691X97000332; http://api.elsevier.com/content/article/PII:S0093691X97000332?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0093691X97000332?httpAccept=text/plain; http://dx.doi.org/10.1016/s0093-691x%2897%2900033-2; https://dx.doi.org/10.1016/s0093-691x%2897%2900033-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know